JFG
INBX icon

Jefferies Financial Group’s Inhibrx INBX Stock Holding History

Jefferies Financial Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.96M Buy
73,416
+34,443
+88% +$3.45M 0.05% 317
2026
Q1 		$2.62M Buy
38,973
+30,072
+338% +$2.23M 0.02% 521
2025
Q4 		$703K Buy
+8,901
New +$606K ﹤0.01% 1233

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jefferies Financial Group's INBX Position: Q2 2026 in Review

Jefferies Financial Group increased its Inhibrx (INBX) stake by 88% in Q2 2026, buying an estimated $3.45M and bringing the position to 73,416 shares worth $6.96M. The position accounts for 0.05% of the portfolio, ranked #317.

Jefferies Financial Group first reported a position in INBX in Q4 2025 and has held it in 3 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Jefferies Financial Group held 73,416 shares of Inhibrx worth $6.96M as of Q2 2026.
  • Jefferies Financial Group bought 34,443 Inhibrx shares in Q2 2026, an estimated $3.45M.
  • Inhibrx made up 0.05% of Jefferies Financial Group's portfolio in Q2 2026, its #317 holding.
  • Jefferies Financial Group first reported a position in Inhibrx in Q4 2025 and has held it in 3 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.